David Baker, the 2024 Nobel Prize winner in chemistry, is also a co-founder of the new company. Seattle-based Archon Biosciences launched from stealth Wednesday with $20 million in seed funding.
Archon Biosciences has launched with $20 million to design custom antibody cages with the help of AI. The Seattle-based company spun out of the lab of the 2024 Nobel laureate David Baker at the ...